Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma.
about
Structure-Based Design of Orally Bioavailable 1 H -Pyrrolo[3,2- c ]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)The prevalence and expression pattern of melanoma-associated antigen 1 in esophageal squamous cell carcinoma: a historical cohort studyCurrent status of cancer immunotherapyIdentification of immunogenic LY6K long peptide encompassing both CD4(+) and CD8(+) T-cell epitopes and eliciting CD4(+) T-cell immunity in patients with malignant diseasePhase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients.Immunotherapy for lung cancers.TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability.Immunogenic tumor cell death induced by chemoradiotherapy in a clinical settingWhole-genome duplication increases tumor cell sensitivity to MPS1 inhibition.Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma.Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancerPhase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer.A systematic approach to the development of novel therapeutics for lung cancer using genomic analyses.Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.ANTI-TUMOR IMMUNE RESPONSES INDUCED BY RADIOTHERAPY: A REVIEW.Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer.An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs.Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.Mps1/TTK: a novel target and biomarker for cancer.Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4- d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N-(2-Ethoxy-4-(4-methyl-4 H-1,2,4-triazol-3-yl)phenyl)-6-methyl- N-neopentyl
P2860
Q27680652-49F9AD34-14E2-42B6-B4C4-77A8757AB7B9Q33620367-70EF1482-3639-4551-96D5-87264FE10EDAQ33955720-315DC279-D747-463E-8DF6-600ED1C5A662Q34372937-955EB841-A927-4F5F-9CC6-E28F49FE4608Q34522972-90F6A057-DA9A-458E-A993-0D4FA3859AACQ34557611-626906A4-5BEB-4FCC-AD0D-F7891ABDBBEFQ34735167-47F749E5-10C3-4D8C-A190-484CCAB4F6E6Q36112645-0887A0B9-F409-4DB4-9927-6E025085E8E0Q36336091-C48316B7-75D0-4CCA-B2DE-73C74A679B72Q36643618-610C8F46-1D5C-4D1C-A9B9-743EA456A4C6Q36729558-D958DD1E-349E-4762-A587-D47D9ADD429CQ36965049-F66A0A98-DDB7-488A-A62F-048C3D7F9D8EQ36985164-B28B28B2-98C6-4CAE-B79A-81BD1FADFF05Q37251564-40E187EA-7A05-4EF1-8C02-FA381DDBDBF7Q37591955-411F5582-9F49-4279-BD93-9A81C5A59046Q38105238-792BA16A-9443-4F2F-B994-7ADBB24610B0Q38406799-C7EFE1D0-F8CD-4375-A3FC-56945E432F06Q38541959-D9A90DD7-1319-4BD4-AA2D-142FF5B540A3Q41505635-01488EEB-F9A4-4798-8F06-192BC259A812Q42427592-3F8DA34F-D31E-41F5-A14F-E97154AE531DQ45783352-EB3433F4-B7EE-41CD-9206-C9151E3163E6Q51074812-9FEB518C-8766-438A-971C-FF72224113BEQ58753054-6F89933B-6E82-43B9-8137-305248F4C2E8
P2860
Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Detection of novel cancer-test ...... ageal squamous cell carcinoma.
@en
Detection of novel cancer-test ...... ageal squamous cell carcinoma.
@nl
type
label
Detection of novel cancer-test ...... ageal squamous cell carcinoma.
@en
Detection of novel cancer-test ...... ageal squamous cell carcinoma.
@nl
prefLabel
Detection of novel cancer-test ...... ageal squamous cell carcinoma.
@en
Detection of novel cancer-test ...... ageal squamous cell carcinoma.
@nl
P2093
P2860
P1433
P1476
Detection of novel cancer-test ...... ageal squamous cell carcinoma.
@en
P2093
Atsushi Takano
Hideki Fujii
Takuya Tsunoda
Yataro Daigo
Yoshihiko Kawaguchi
Yoshiki Mizukami
Yusuke Nakamura
P2860
P304
P356
10.1111/J.1349-7006.2008.00844.X
P577
2008-04-30T00:00:00Z